XBiotech XBIT
NASDAQ XBIT
$2.31 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

XBiotech (XBIT) Long-Term Deferred Tax (2019 - 2022)

XBiotech (XBIT) posted quarterly Long-Term Deferred Tax of $772000.0 for Q3 2022, up 20.25% year-over-year from $642000.0 in Q3 2021, and up 82.94% quarter-over-quarter from $422000.0 in Q2 2022.

XBiotech (XBIT) Long-Term Deferred Tax (2019 - 2022) Analysis & Trends

XBiotech's Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $772000.0 for Q3 2022.

  • In Q3 2022, Long-Term Deferred Tax rose 20.25% year-over-year to $772000.0; the TTM figure through Sep 2022 stood at $772000.0 (up 20.25% YoY), while the FY2020 annual figure was $533000.0, up 20.32% from the prior year.
  • Long-Term Deferred Tax for Q3 2022 stood at $772000.0, up from $422000.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $772000.0 in Q3 2022, with the low at $422000.0 in Q2 2022.
  • The 4-year median for Long-Term Deferred Tax is $488000.0 (2019), against an average of $531600.0.
  • The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax soared 44.92% in 2021, then sank 34.27% in 2022.
  • XBiotech's Long-Term Deferred Tax stood at $443000.0 in 2019, then rose by 20.32% to $533000.0 in 2020, then rose by 20.45% to $642000.0 in 2021, then climbed by 20.25% to $772000.0 in 2022.
  • Business Quant data shows XBIT's Long-Term Deferred Tax at $772000.0 in Q3 2022, $422000.0 in Q2 2022, and $642000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 XBiotech 68.90 Mn 68.90 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 772,000.00
Jun 30, 2022 422,000.00
Sep 30, 2021 642,000.00
Jun 30, 2021 642,000.00
Mar 31, 2021 533,000.00
Dec 31, 2020 533,000.00
Sep 30, 2020 443,000.00
Jun 30, 2020 443,000.00
Mar 31, 2020 443,000.00
Dec 31, 2019 443,000.00